Navigation Links
Acclaimed chemistry professor wins 2 major awards
Date:7/29/2011

continues to develop Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry, a powerful analytical procedure capable of resolving and identifying thousands of different chemical components in complex mixtures ranging from petroleum to biological fluids. Since its invention, more than 775 FT-ICR instruments, with a replacement value of approximately $450 million, have been installed in laboratories worldwide.

The William H. Nichols Medal will be given in recognition of Marshall's outstanding achievements in the chemical sciences, especially in the area of FT-ICR mass spectroscopy. The Nichols Medal, established in 1903, is one of the oldest and most prestigious awards of the New York Section of the ACS. Sixteen previous Nichols Medalists have gone on to win the Nobel Prize in Chemistry. Marshall will receive the award during the annual William H. Nichols Distinguished Symposium in White Plains, N.Y., in March 2012.

The Pittsburgh Analytical Chemistry Award will be given to recognize Marshall's significant contributions to the field of analytical chemistry. He will receive that award during Pittcon, the world's largest conference and exposition on laboratory science, in Orlando, Fla., in March 2012. He will become only the fourth scientist to receive the three main awards of the SACP. The other two are the SACP Maurice F. Hasler Award, which Marshall won in 1997, and the Spectroscopy Society of Pittsburgh Spectroscopy Award, which he won in 2002.

"It is gratifying that both awards recognize research conducted during my 18 years at Florida State, made possible by dozens of clever and accomplished colleagues, ranging from undergraduate and graduate students to staff and faculty members here and elsewhere," Marshall said.

In recent years, Marshall's research group (http://www.magnet.fsu.edu/usershub/scientificdivisions/icr/index.html) has received a great deal of attention for its development of "petroleomics," an entirel
'/>"/>

Contact: Alan Marshall
amarshall@fsu.edu
850-644-0259
Florida State University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
2. Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant
3. Leicesters internationally acclaimed genetics research involved in project into saffron production
4. Research center to free chemistry from Earths bonds
5. Volcanoes may have provided sparks and chemistry for first life
6. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
7. Biochemistry of human physiology in health and disease is focus of updated clinical text
8. International public-private partnership offers new paradigm for medicinal chemistry
9. Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
10. Phytoplankton cell membranes challenge fundamentals of biochemistry
11. British journal publishes inorganic chemistry research of NJIT professor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Acclaimed chemistry professor wins 2 major awards
(Date:9/16/2014)... Menopause Society (NAMS) has published its key, evidence-based ... everything from hot flashes to heart disease. The ... for Clinical Care of Midlife Women," was published ... . This is the first, comprehensive set of ... freely available to all clinicians who care for ...
(Date:9/16/2014)... Two Johns Hopkins neuroscientists have discovered the "molecular brakes" ... inner ear cochleas of mice. These "hair cells" translate ... the brain and are interpreted as sounds. If the ... , A summary of the research will be ... Sept. 16. , "The proteins Hey1 and Hey2 act ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3
... world,s top biodiversity hotspot for reptiles and amphibians, according ... from the University of California, Berkeley, Southern Illinois University ... The park, which encompasses lowland Amazonian rain forest, high-altitude ... well known for its huge variety of bird life, ...
... to climate change are being compiled by research groups ... various sources results in different climate projections; hence, the ... arrive at a consensus regarding future climate estimates. ... SIAM Journal on Uncertainty Quantification , authors Matthew ...
... , New Rochelle, NY, February 19, 2014Joseph C. Glorioso, ... devoted much of his research career to developing herpes ... cells. In recognition of his leadership and accomplishments, ... Gene Therapy , a peer-reviewed journal from Mary Ann ...
Cached Biology News:Peru's Manu National Park sets new biodiversity record 2Peru's Manu National Park sets new biodiversity record 3Statistics research could build consensus around climate predictions 2Statistics research could build consensus around climate predictions 3Statistics research could build consensus around climate predictions 4Joseph Glorioso, Ph.D., receives Pioneer Award 2
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... 17, 2014 A biodegradable polymer ... such as bacteria, fungi, and algae into smaller ... biomass, inorganic compounds, carbon dioxide, and humus in ... base and improved costs, biodegradable polymers are proving ... alternative to conventional polymers. Primary factors that are ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
Breaking Biology Technology:Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4
... 15, 2011 Generex Biotechnology Corporation ( www.generex.com ... the status of the previously announced spinout of ... ). The Company is in the ... several transaction opportunities, including both shell companies and ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced ... provide an overview of the company,s business strategy at ... the UBS 2011 Global Life Sciences Conference which will ... addition, Geoffrey Nichol, M.B., Ch.B., Sangamo,s executive vice president ...
... Aperion Biologics, Inc. announced that it has reached ... Company,s clinical trial of its Z-Lig™ Anterior Cruciate Ligament ... of the knee. The randomized multicenter study commenced in ... provide safety and performance data in the reconstruction of ...
Cached Biology Technology:Generex Provides Update on Spinout of Antigen Express 2Generex Provides Update on Spinout of Antigen Express 3Generex Provides Update on Spinout of Antigen Express 4Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference 2Aperion Biologics Reaches Midpoint of Enrollment in Z-Lig™ Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial 2